Six Month Safety and Efficacy of the Pfizer BNT162b2 mRNA COVID-19 Vaccine

Mito

Member
Joined
Dec 10, 2016
Messages
2,554
ABSTRACT

Background
: BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. BNT162b2 is highly efficacious against COVID-19 and is currently authorized for emergency use or conditional approval worldwide. At the time of authorization, data beyond 2 months post- vaccination were unavailable.

Methods: In an ongoing, placebo-controlled, observer-blinded, multinational, pivotal efficacy study, 44,165 ≥16-year-old participants and 2,264 12-15-year-old participants were randomized to receive 2 doses, 21 days apart, of 30 μg BNT162b2 or placebo. Study endpoints reported here are vaccine efficacy (VE) against laboratory-confirmed COVID-19 and safety data, both up to 6 months post-vaccination.

Results: BNT162b2 continued to be safe and well tolerated. Few participants had adverse events leading to study withdrawal. VE against COVID-19 was 91% (95% CI 89.0‒93.2) through up to 6 months of follow-up, among evaluable participants and irrespective of previous SARS-CoV-2 infection. VE of 86%‒100% was seen across countries and in populations with diverse characteristics of age, sex, race/ethnicity, and COVID-19 risk factors in participants without evidence of previous SARS-CoV-2 infection. VE against severe disease was 97% (95% CI 80.3‒ 99.9). In South Africa, where the SARS-CoV-2 variant of concern, B.1.351 (beta), was predominant, 100% (95% CI 53.5, 100.0) VE was observed.

Conclusion: With up to 6 months of follow-up and despite a gradually declining trend in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing COVID-19. (ClinicalTrials.gov number, NCT04368728)


B3AF9CD4-856C-4E3C-A27A-5FFD98D63864.jpeg

 
Last edited:

LLight

Member
Joined
May 30, 2018
Messages
1,411
Is this the publication where all causes mortality is the same whether they have been vaccinated or not?
 

tankasnowgod

Member
Joined
Jan 25, 2014
Messages
8,131
One more death in vax group than placebo.

It might be a lot more that just one. Every death may have been post vaxxxine. The report even says that most in the "Placebo" group have now received the Pfizer shot. I wouldn't put it past this criminal organization to continue to fake the data. Remember, the original report had an extra 251 people missing from the Vax group as compared to the original placebo, as Peter Doshi pointed out back in January. That was more than the 170 total "Covid" cases, at the time.

They probably pulled the same shenanigans this time.
 

Mephisto

Member
Joined
Feb 10, 2013
Messages
96
I wonder if their saline placebo was really saline. In the HPV vax trials, the placebos used were either aluminum based on another vax.
 
OP
Mito

Mito

Member
Joined
Dec 10, 2016
Messages
2,554
It might be a lot more that just one. Every death may have been post vaxxxine. The report even says that most in the "Placebo" group have now received the Pfizer shot. I wouldn't put it past this criminal organization to continue to fake the data. Remember, the original report had an extra 251 people missing from the Vax group as compared to the original placebo, as Peter Doshi pointed out back in January. That was more than the 170 total "Covid" cases, at the time.

They probably pulled the same shenanigans this time.
The only person that died from COVID-19 pneumonia was in vax group.
 

tankasnowgod

Member
Joined
Jan 25, 2014
Messages
8,131
The only person that died from COVID-19 pneumonia was in vax group.

Interesting.

So, by the results from this trial, we can gather that you have an infinitely larger change of dying from COVID 19 if you take the Pfizer vaccine. I mean, I am doing Relative Risk calculations correctly, yes?
 

Fred

Member
Joined
Jul 25, 2013
Messages
487
All-cause mortality is the figure we should be looking at. If the vaccine itself is harmful, then that's where it would show up in the data. Ironically, if the vaccine killed everyone right away, using the metric of "how many died of covid" would make the vaccine look like a rousing success, since the vaxxed wouldn't be alive long enough to die of covid!
 
P

Peatness

Guest
 

Fred

Member
Joined
Jul 25, 2013
Messages
487
View attachment 30286

Interesting. Thanks! Even the rigged trial couldn't show that it saved lives overall. Here's someone looking at UK data for all-cause mortality vaxxed vs. unvaxxed (UK only published this data once, as far as I can tell ... and I looked for quite a while.) Not looking good:

 

ddjd

Member
Joined
Jul 13, 2014
Messages
6,723
ABSTRACT

Background
: BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. BNT162b2 is highly efficacious against COVID-19 and is currently authorized for emergency use or conditional approval worldwide. At the time of authorization, data beyond 2 months post- vaccination were unavailable.

Methods: In an ongoing, placebo-controlled, observer-blinded, multinational, pivotal efficacy study, 44,165 ≥16-year-old participants and 2,264 12-15-year-old participants were randomized to receive 2 doses, 21 days apart, of 30 μg BNT162b2 or placebo. Study endpoints reported here are vaccine efficacy (VE) against laboratory-confirmed COVID-19 and safety data, both up to 6 months post-vaccination.

Results: BNT162b2 continued to be safe and well tolerated. Few participants had adverse events leading to study withdrawal. VE against COVID-19 was 91% (95% CI 89.0‒93.2) through up to 6 months of follow-up, among evaluable participants and irrespective of previous SARS-CoV-2 infection. VE of 86%‒100% was seen across countries and in populations with diverse characteristics of age, sex, race/ethnicity, and COVID-19 risk factors in participants without evidence of previous SARS-CoV-2 infection. VE against severe disease was 97% (95% CI 80.3‒ 99.9). In South Africa, where the SARS-CoV-2 variant of concern, B.1.351 (beta), was predominant, 100% (95% CI 53.5, 100.0) VE was observed.

Conclusion: With up to 6 months of follow-up and despite a gradually declining trend in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing COVID-19. (ClinicalTrials.gov number, NCT04368728)


View attachment 26150

View: https://twitter.com/backtolife_2019/status/1487787222279634957?t=RrgTO9mrAdX69Dzf9ojxIw&s=19
 

Fred

Member
Joined
Jul 25, 2013
Messages
487


Ray was talking about the "blood brain barrier" on Timpone a couple months ago, and he said that the "barrier" doesn't exist, per se ... it's just that the brain only absorbs fats, so it is a "barrier" to non-fatty substances. He didn't mention the lipid nanoparticles, but I remember thinking that the LNPs would probably be able to cross this "barrier" ... almost certainly by design. What is going to happen with these vaccines? I think "science fiction"-type options should be on the table here.
 
OP
Mito

Mito

Member
Joined
Dec 10, 2016
Messages
2,554
What is going to happen with these vaccines? I think "science fiction"-type options should be on the table here.
A natural infection with SARS-CoV-2 (coronavirus) will in most individuals remain localized to the respiratory tract. In contrast, the vaccines cause cells deep inside our body to express the viral spike protein, which they were never meant to do by nature. Any cell which expresses this foreign antigen will come under attack by the immune system, which will involve both IgG antibodies and cytotoxic T- lymphocytes. This may occur in any organ. We are seeing now that the heart is affected in many young people, leading to myocarditis or even sudden cardiac arrest and death. How and why such tragedies might causally be linked to vaccination has remained a matter of conjecture because scientific evidence has been lacking.”

Histopathologic analysis show clear evidence of vaccine-induced autoimmune-like pathology in multiple organs. That myriad adverse events deriving from such auto-attack processes must be expected to very frequently occur in all individuals, particularly following booster injections, is self- evident. Beyond any doubt, injection of gene-based COVID-19 vaccines places lives under threat of illness and death. We note that both mRNA and vector-based vaccines are represented among these cases, as are all four major manufacturers.

 
EMF Mitigation - Flush Niacin - Big 5 Minerals

Similar threads

Back
Top Bottom